The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLWB.L Regulatory News (LWB)

  • There is currently no data for LWB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year-end update

14 Jan 2020 07:00

RNS Number : 6678Z
Low & Bonar PLC
14 January 2020
 

14 January 2020

Low & Bonar PLC

Year-end update

Low & Bonar PLC ("Low & Bonar" or the "Group"), the international performance materials group, today issues updates on the Group's trading and financial position for the year ended 30 November 2019, and on the previously announced, and shareholder-approved, proposed acquisition of the Group by FV-Beteiligungs-GmbH ("Freudenberg") (the "Acquisition").

Trading and financial position

Further to the trading update of 20 September 2019, conditions affecting the Group's trading remained largely unchanged during the period to 30 November 2019. As a result, the Board currently expects, subject to audit, reported revenue for the year to 30 November 2019 from continuing operations to be £317m, underlying EBITDA to be approximately £18m and underlying profitability before taxation and amortisation to be approximately break-even (the "Low & Bonar Profit Estimate").

Net debt at 30 November 2019, subject to audit, was approximately £97m.

As announced on 10 October 2019, agreement was reached with Low & Bonar's lenders to amend the terms of the Group's financing facilities to assist the Company in progressing the Acquisition. As part of these amendments the testing of financial covenants as at 30 November 2019 was waived. As set out on 10 October 2019, should the Acquisition lapse, covenants would be reinstated and tested within 14 days with respect to the financial position as at the month-end previous to such lapse. In the event that the Acquisition does not complete by 30 June 2020, the scheduled covenant test as at 31 May 2020 would occur. Shareholders should note that there remains a significant risk that, should the financial covenants be tested, the Group would fail to comply.

Acquisition update

As announced on 5 November 2019, the Acquisition has been approved by the Group's shareholders. Competition approval remains the key outstanding condition to the completion of the Acquisition. The European Commission has confirmed that the transaction will be reviewed at the European level and this review is ongoing in the normal course. The competition approval required in Russia has been received.

Low & Bonar Profit Estimate

The Low & Bonar Profit Estimate constitutes a profit estimate for the purposes of Rule 28 of the Takeover Code. The Low & Bonar Directors confirm that the Low & Bonar Estimate is valid and has been properly compiled on the basis stated subsequently and on a basis consistent with the accounting policies of Low & Bonar. The Low & Bonar Directors prepared the Low & Bonar Profit Estimate on the basis of the unaudited management accounts of Low & Bonar for the year ended 30 November 2019.

For further information, please contact:

Low & Bonar PLC

 

 

Daniel Dayan

Executive Chairman

020 7535 3180 

Ian Ashton

Group CFO

 

 

 

 

Instinctif Partners

 

020 7457 2020

Matthew Smallwood

 

 

Rosie Driscoll

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBJMMTMTIBTPM
Date   Source Headline
19th Feb 20197:00 amRNSResults of Placing and Open Offer
12th Feb 201912:07 pmRNSSecond Price Monitoring Extn
12th Feb 201912:02 pmRNSPrice Monitoring Extension
11th Feb 201912:07 pmRNSSecond Price Monitoring Extn
11th Feb 201912:02 pmRNSPrice Monitoring Extension
1st Feb 201912:02 pmRNSPrice Monitoring Extension
30th Jan 20192:19 pmRNSPublication of Prospectus
30th Jan 20197:16 amRNSProposed Firm Placing and Placing and Open Offer
30th Jan 20197:12 amRNSFinal Results
31st Dec 20188:00 amRNSTotal Voting Rights
24th Dec 201812:41 pmRNSSecond Price Monitoring Extn
24th Dec 201812:35 pmRNSPrice Monitoring Extension
21st Dec 20184:36 pmRNSPrice Monitoring Extension
14th Dec 20187:00 amRNSTrading Update
3rd Dec 20187:00 amRNSDirectorate Change
30th Nov 20184:23 pmRNSDirector Declaration
30th Nov 201811:45 amRNSTotal Voting Rights
23rd Nov 20189:00 amRNSAudit Tender Outcome
14th Nov 20184:35 pmRNSPrice Monitoring Extension
9th Nov 20184:40 pmRNSSecond Price Monitoring Extn
9th Nov 20184:35 pmRNSPrice Monitoring Extension
1st Nov 20184:40 pmRNSSecond Price Monitoring Extn
1st Nov 20184:35 pmRNSPrice Monitoring Extension
31st Oct 20182:14 pmRNSTotal Voting Rights
15th Oct 20184:40 pmRNSSecond Price Monitoring Extn
15th Oct 20184:35 pmRNSPrice Monitoring Extension
5th Oct 201812:57 pmRNSHolding(s) in Company
3rd Oct 201812:17 pmRNSDirector/PDMR Shareholding
1st Oct 201810:46 amRNSTotal Voting Rights
28th Sep 20181:54 pmRNSHolding(s) in Company
28th Sep 20189:00 amRNSHolding(s) in Company
28th Sep 20189:00 amRNSHolding(s) in Company
26th Sep 20183:47 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSTrading Update
31st Aug 20184:16 pmRNSTotal Voting Rights
23rd Aug 20184:20 pmRNSHolding(s) in Company
20th Aug 20187:00 amRNSDirector/PDMR Shareholding
14th Aug 20183:31 pmRNSDirector/PDMR Shareholding
8th Aug 20187:00 amRNSChairman succession
1st Aug 20188:57 amRNSTotal Voting Rights
11th Jul 20187:00 amRNSHalf-year Report
4th Jul 20184:35 pmRNSPrice Monitoring Extension
2nd Jul 20182:33 pmRNSTotal Voting Rights
6th Jun 20187:00 amRNSNotice of Results
1st Jun 20188:30 amRNSTotal Voting Rights
17th May 201812:37 pmRNSDirector/PDMR Shareholding
17th May 20187:00 amRNSDebt refinancing
11th May 201811:26 amRNSDirector/PDMR Shareholding
1st May 20189:36 amRNSTotal Voting Rights
20th Apr 20188:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.